Joshua M Hare
Quick facts
Phase 2 pipeline
- Allogeneic hMSCs
Mesenchymal stem cells exert immunomodulatory and tissue regenerative effects through paracrine signaling and differentiation capabilities.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies